Epizyme: 3Q Earnings Snapshot

October 30, 2019

CAMBRIDGE, Mass. (AP) _ Epizyme Inc. (EPZM) on Wednesday reported a loss of $36.1 million in its third quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 40 cents.

The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 54 cents per share.

The biopharmaceutical company posted revenue of $5.7 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $5.5 million.

Epizyme shares have increased 71% since the beginning of the year. The stock has increased 25% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EPZM at https://www.zacks.com/ap/EPZM